| Year |
Citation |
Score |
| 2024 |
Moreno N, Sabater-Arcis M, Sevilla T, Alonso MP, Ohana J, Bargiela A, Artero R. Therapeutic potential of oleic acid supplementation in myotonic dystrophy muscle cell models. Biological Research. 57: 29. PMID 38760841 DOI: 10.1186/s40659-024-00496-z |
0.315 |
|
| 2023 |
Sabater-Arcis M, Moreno N, Sevilla T, Perez Alonso M, Bargiela A, Artero R. Msi2 enhances muscle dysfunction in a myotonic dystrophy type 1 mouse model. Biomedical Journal. 100667. PMID 37797921 DOI: 10.1016/j.bj.2023.100667 |
0.346 |
|
| 2023 |
Overby SJ, Cerro-Herreros E, Espinosa-Espinosa J, González-Martínez I, Moreno N, Fernández-Costa JM, Balaguer-Trias J, Ramón-Azcón J, Pérez-Alonso M, Møller T, Llamusí B, Artero R. BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA Mice. Pharmaceutics. 15. PMID 37111604 DOI: 10.3390/pharmaceutics15041118 |
0.354 |
|
| 2023 |
Poyatos-García J, Blázquez-Bernal Á, Selva-Giménez M, Bargiela A, Espinosa-Espinosa J, Vázquez-Manrique RP, Bigot A, Artero R, Vilchez JJ. CRISPR-Cas9 editing of a TNPO3 mutation in a muscle cell model of limb-girdle muscular dystrophy type D2. Molecular Therapy. Nucleic Acids. 31: 324-338. PMID 36789274 DOI: 10.1016/j.omtn.2023.01.004 |
0.333 |
|
| 2021 |
Sabater-Arcis M, Bargiela A, Moreno N, Poyatos-Garcia J, Vilchez JJ, Artero R. Musashi-2 contributes to myotonic dystrophy muscle dysfunction by promoting excessive autophagy through biogenesis repression. Molecular Therapy. Nucleic Acids. 25: 652-667. PMID 34589284 DOI: 10.1016/j.omtn.2021.08.010 |
0.412 |
|
| 2021 |
Blázquez-Bernal Á, Fernandez-Costa JM, Bargiela A, Artero R. Inhibition of autophagy rescues muscle atrophy in a LGMDD2 Drosophila model. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21914. PMID 34547132 DOI: 10.1096/fj.202100539RR |
0.39 |
|
| 2021 |
Cerro-Herreros E, González-Martínez I, Moreno N, Espinosa-Espinosa J, Fernández-Costa JM, Colom-Rodrigo A, Overby SJ, Seoane-Miraz D, Poyatos-García J, Vilchez JJ, López de Munain A, Varela MA, Wood MJ, Pérez-Alonso M, Llamusí B, ... Artero R, et al. Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy. Molecular Therapy. Nucleic Acids. 26: 174-191. PMID 34513303 DOI: 10.1016/j.omtn.2021.07.017 |
0.401 |
|
| 2020 |
Ozimski LL, Sabater-Arcis M, Bargiela A, Artero R. The hallmarks of myotonic dystrophy type 1 muscle dysfunction. Biological Reviews of the Cambridge Philosophical Society. PMID 33269537 DOI: 10.1111/brv.12674 |
0.318 |
|
| 2020 |
Cerro-Herreros E, González-Martínez I, Moreno-Cervera N, Overby S, Pérez-Alonso M, Llamusí B, Artero R. Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy. Molecular Therapy. Nucleic Acids. 21: 837-849. PMID 32805487 DOI: 10.1016/j.omtn.2020.07.021 |
0.387 |
|
| 2020 |
Selma-Soriano E, Llamusi B, Fernández-Costa JM, Ozimski LL, Artero R, Redón J. Rabphilin involvement in filtration and molecular uptake in nephrocytes suggests a similar role in human podocytes. Disease Models & Mechanisms. PMID 32680845 DOI: 10.1242/dmm.041509 |
0.44 |
|
| 2020 |
Ramon-Duaso C, Rodríguez-Morató J, Selma-Soriano E, Fernández-Avilés C, Artero R, de la Torre R, Pozo ÓJ, Robledo P. Protective effects of mirtazapine in mice lacking the Mbnl2 gene in forebrain glutamatergic neurons: Relevance for myotonic dystrophy 1. Neuropharmacology. 108030. PMID 32171677 DOI: 10.1016/j.neuropharm.2020.108030 |
0.337 |
|
| 2019 |
Konieczny P, Artero R. Drosophila SMN2 minigene reporter model identifies moxifloxacin as a candidate therapy for SMA. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 31909520 DOI: 10.1096/fj.201802554RRR |
0.324 |
|
| 2019 |
Sabater-Arcis M, Bargiela A, Furling D, Artero R. miR-7 Restores Phenotypes in Myotonic Dystrophy Muscle Cells by Repressing Hyperactivated Autophagy. Molecular Therapy. Nucleic Acids. 19: 278-292. PMID 31855836 DOI: 10.1016/j.omtn.2019.11.012 |
0.323 |
|
| 2019 |
Bargiela A, Sabater-Arcis M, Espinosa-Espinosa J, Zulaica M, Lopez de Munain A, Artero R. Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models. Proceedings of the National Academy of Sciences of the United States of America. PMID 31754023 DOI: 10.1073/pnas.1820297116 |
0.416 |
|
| 2019 |
López Castel A, Overby SJ, Artero R. MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy. International Journal of Molecular Sciences. 20. PMID 31717488 DOI: 10.3390/ijms20225600 |
0.303 |
|
| 2018 |
Overby SJ, Cerro-Herreros E, Llamusi B, Artero R. RNA-mediated therapies in myotonic dystrophy. Drug Discovery Today. PMID 30086404 DOI: 10.1016/j.drudis.2018.08.004 |
0.406 |
|
| 2018 |
Cerro-Herreros E, Sabater-Arcis M, Fernandez-Costa JM, Moreno N, Perez-Alonso M, Llamusi B, Artero R. miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models. Nature Communications. 9: 2482. PMID 29946070 DOI: 10.1038/s41467-018-04892-4 |
0.308 |
|
| 2018 |
Sellier C, Cerro-Herreros E, Blatter M, Freyermuth F, Gaucherot A, Ruffenach F, Sarkar P, Puymirat J, Udd B, Day JW, Meola G, Bassez G, Fujimura H, Takahashi MP, Schoser B, ... ... Artero R, et al. rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences. Nature Communications. 9: 2009. PMID 29789616 DOI: 10.1038/S41467-018-04370-X |
0.356 |
|
| 2018 |
Selma-Soriano E, Artero R, Llamusi B. Optical Cross-Sectional Muscle Area Determination of Drosophila Melanogaster Adult Indirect Flight Muscles. Journal of Visualized Experiments : Jove. PMID 29658931 DOI: 10.3791/56179 |
0.409 |
|
| 2018 |
Chakraborty M, Sellier C, Ney M, Villa P, Charlet-Berguerand N, Artero R, Llamusi B. Daunorubicin reduces MBNL1 titration by expanded CUG repeat RNA and rescues cardiac dysfunctions in amodel of myotonic dystrophy. Disease Models & Mechanisms. PMID 29592894 DOI: 10.1242/dmm.032557 |
0.314 |
|
| 2017 |
Calpena E, López Del Amo V, Chakraborty M, Llamusí B, Artero R, Espinós C, Galindo MI. The Drosophila junctophilin gene is functionally equivalent to its four mammalian counterparts and is a modifier of a Huntingtin poly-Q expansion and the Notch pathway. Disease Models & Mechanisms. PMID 29208631 DOI: 10.1242/dmm.029082 |
0.461 |
|
| 2017 |
Konieczny P, Selma-Soriano E, Rapisarda AS, Fernandez-Costa JM, Perez-Alonso M, Artero R. Myotonic dystrophy: candidate small molecule therapeutics. Drug Discovery Today. PMID 28780071 DOI: 10.1016/j.drudis.2017.07.011 |
0.414 |
|
| 2017 |
Cerro-Herreros E, Chakraborty M, Pérez-Alonso M, Artero R, Llamusí B. Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes. Scientific Reports. 7: 2843. PMID 28588248 DOI: 10.1038/s41598-017-02829-3 |
0.455 |
|
| 2017 |
González ÀL, Konieczny P, Llamusi B, Delgado-Pinar E, Borrell JI, Teixidó J, García-España E, Pérez-Alonso M, Estrada-Tejedor R, Artero R. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models. Plos One. 12: e0178931. PMID 28582438 DOI: 10.1371/journal.pone.0178931 |
0.353 |
|
| 2016 |
Cerro-Herreros E, Fernandez-Costa JM, Sabater-Arcis M, Llamusi B, Artero R. Derepressing muscleblind expression by miRNA sponges ameliorates myotonic dystrophy-like phenotypes in Drosophila. Scientific Reports. 6: 36230. PMID 27805016 DOI: 10.1038/srep36230 |
0.441 |
|
| 2015 |
Chakraborty M, Selma-Soriano E, Magny E, Couso JP, Pérez-Alonso M, Charlet-Berguerand N, Artero R, Llamusi B. Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction. Disease Models & Mechanisms. PMID 26515653 DOI: 10.1242/dmm.021428 |
0.324 |
|
| 2015 |
Bargiela A, Cerro-Herreros E, Fernandez-Costa JM, Vilchez JJ, Llamusi B, Artero R. Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model. Disease Models & Mechanisms. 8: 679-90. PMID 26092529 DOI: 10.1242/dmm.018127 |
0.428 |
|
| 2014 |
García-Alcover I, Colonques-Bellmunt J, Garijo R, Tormo JR, Artero R, Álvarez-Abril MC, López Castel A, Pérez-Alonso M. Development of a Drosophila melanogaster spliceosensor system for in vivo high-throughput screening in myotonic dystrophy type 1. Disease Models & Mechanisms. 7: 1297-306. PMID 25239918 DOI: 10.1242/dmm.016592 |
0.377 |
|
| 2014 |
Llamusí B, Muñoz-Soriano V, Paricio N, Artero R. The use of whole-mount in situ hybridization to illustrate gene expression regulation. Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology. 42: 339-47. PMID 24979316 DOI: 10.1002/bmb.20807 |
0.387 |
|
| 2014 |
Bargiela A, Llamusi B, Cerro-Herreros E, Artero R. Two enhancers control transcription of Drosophila muscleblind in the embryonic somatic musculature and in the central nervous system. Plos One. 9: e93125. PMID 24667536 DOI: 10.1371/journal.pone.0093125 |
0.508 |
|
| 2013 |
Llamusi B, Bargiela A, Fernandez-Costa JM, Garcia-Lopez A, Klima R, Feiguin F, Artero R. Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model. Disease Models & Mechanisms. 6: 184-96. PMID 23118342 DOI: 10.1242/dmm.009563 |
0.509 |
|
| 2011 |
García-López A, Llamusí B, Orzáez M, Pérez-Payá E, Artero RD. In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models. Proceedings of the National Academy of Sciences of the United States of America. 108: 11866-71. PMID 21730182 DOI: 10.1073/pnas.1018213108 |
0.346 |
|
| 2011 |
Fernandez-Costa JM, Llamusi MB, Garcia-Lopez A, Artero R. Alternative splicing regulation by Muscleblind proteins: from development to disease. Biological Reviews of the Cambridge Philosophical Society. 86: 947-58. PMID 21489124 DOI: 10.1111/j.1469-185X.2011.00180.x |
0.426 |
|
| 2010 |
Pascual M, Monferrer L, Fernandez Costa JM, Bargiela A, Artero R, Llamusi B. A GFP-tagged muscleblind C protein isoform reporter construct. Fly. 4: 333-7. PMID 20855964 DOI: 10.4161/fly.4.4.13259 |
0.446 |
|
| 2010 |
Fernandez-Costa JM, Artero R. A conserved motif controls nuclear localization of Drosophila Muscleblind. Molecules and Cells. 30: 65-70. PMID 20652497 DOI: 10.1007/s10059-010-0089-9 |
0.431 |
|
| 2009 |
Weavers H, Prieto-Sánchez S, Grawe F, Garcia-López A, Artero R, Wilsch-Bräuninger M, Ruiz-Gómez M, Skaer H, Denholm B. The insect nephrocyte is a podocyte-like cell with a filtration slit diaphragm. Nature. 457: 322-6. PMID 18971929 DOI: 10.1038/Nature07526 |
0.398 |
|
| 2008 |
Llamusí B, Artero R. Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene. Current Genomics. 9: 509-16. PMID 19516957 DOI: 10.2174/138920208786847944 |
0.475 |
|
| 2008 |
Vicente-Crespo M, Pascual M, Fernandez-Costa JM, Garcia-Lopez A, Monferrer L, Miranda ME, Zhou L, Artero RD. Drosophila muscleblind is involved in troponin T alternative splicing and apoptosis. Plos One. 3: e1613. PMID 18286170 DOI: 10.1371/Journal.Pone.0001613 |
0.375 |
|
| 2008 |
Garcia-Lopez A, Monferrer L, Garcia-Alcover I, Vicente-Crespo M, Alvarez-Abril MC, Artero RD. Genetic and chemical modifiers of a CUG toxicity model in Drosophila. Plos One. 3: e1595. PMID 18270582 DOI: 10.1371/journal.pone.0001595 |
0.302 |
|
| 2007 |
Vicente M, Monferrer L, Poulos MG, Houseley J, Monckton DG, O'dell KM, Swanson MS, Artero RD. Muscleblind isoforms are functionally distinct and regulate alpha-actinin splicing. Differentiation; Research in Biological Diversity. 75: 427-40. PMID 17309604 DOI: 10.1111/J.1432-0436.2006.00156.X |
0.381 |
|
| 2006 |
Artero RD, Monferrer L, Garcia-Lopez A, Baylies MK. Serpent and a hibris reporter are co-expressed in migrating cells during Drosophila hematopoiesis and Malpighian tubule formation. Hereditas. 143: 117-22. PMID 17362344 DOI: 10.1111/j.2006.0018-0661.01928.x |
0.639 |
|
| 2006 |
Pascual M, Vicente M, Monferrer L, Artero R. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing. Differentiation; Research in Biological Diversity. 74: 65-80. PMID 16533306 DOI: 10.1111/j.1432-0436.2006.00060.x |
0.526 |
|
| 2006 |
Monferrer L, Artero R. An interspecific functional complementation test in Drosophila for introductory genetics laboratory courses. The Journal of Heredity. 97: 67-73. PMID 16394256 DOI: 10.1093/jhered/esj003 |
0.425 |
|
| 2005 |
Houseley JM, Wang Z, Brock GJ, Soloway J, Artero R, Perez-Alonso M, O'Dell KM, Monckton DG. Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila. Human Molecular Genetics. 14: 873-83. PMID 15703191 DOI: 10.1093/hmg/ddi080 |
0.495 |
|
| 2003 |
Artero R, Furlong EE, Beckett K, Scott MP, Baylies M. Notch and Ras signaling pathway effector genes expressed in fusion competent and founder cells during Drosophila myogenesis. Development (Cambridge, England). 130: 6257-72. PMID 14602676 DOI: 10.1242/dev.00843 |
0.699 |
|
| 2003 |
Denholm B, Sudarsan V, Pasalodos-Sanchez S, Artero R, Lawrence P, Maddrell S, Baylies M, Skaer H. Dual origin of the renal tubules in Drosophila: mesodermal cells integrate and polarize to establish secretory function. Current Biology : Cb. 13: 1052-7. PMID 12814552 DOI: 10.1016/S0960-9822(03)00375-0 |
0.605 |
|
| 2001 |
Artero RD, Castanon I, Baylies MK. The immunoglobulin-like protein Hibris functions as a dose-dependent regulator of myoblast fusion and is differentially controlled by Ras and Notch signaling. Development (Cambridge, England). 128: 4251-64. PMID 11684661 |
0.694 |
|
| 1998 |
Artero R, Prokop A, Paricio N, Begemann G, Pueyo I, Mlodzik M, Perez-Alonso M, Baylies MK. The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. Developmental Biology. 195: 131-43. PMID 9520330 DOI: 10.1006/Dbio.1997.8833 |
0.686 |
|
| 1997 |
Begemann G, Paricio N, Artero R, Kiss I, Pérez-Alonso M, Mlodzik M. muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. Development (Cambridge, England). 124: 4321-31. PMID 9334280 |
0.353 |
|
| Show low-probability matches. |